Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeiger Counter Regulatory News (GCL)

Share Price Information for Geiger Counter (GCL)

Share Price is delayed by 15 minutes
Get Live Data
72.80    2.20 (3.13%)
Bid:
71.00
Ask:
74.60
Spread: 3.60 (5.07%)
Market Cap: £91.33m
GCL Live PriceLast checked at - London Stock Exchange

Intraday Geiger Counter Share Chart

Entry into Standstill Agreement

1 Jul 2025 07:31

RNS Number : 1620P
Geiger Counter Ltd
01 July 2025
 

THIS ANNOUNCEMENT CONTAINS INFORMATION THAT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) No. 5985/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED

Geiger Counter Limited (or the "Company")

1 July 2025

Entry into Standstill Agreement

The Company is pleased to announce that, following constructive engagement with Saba Capital Management, L.P. ("Saba"), it has agreed the terms of a Standstill Agreement.

Under the terms of the Standstill Agreement, Saba has agreed, amongst other things: that Saba shall not, and shall procure that its affiliates shall not, during the Standstill Period (i) require the Board to convene a general meeting of the Company pursuant to Jersey law; or (ii) exercise any voting rights available to remove, or publicly propose the removal of, any member of the Board. In addition, until the expiry or termination of the Standstill Period, Saba shall not, and shall use its reasonable endeavours to procure that its affiliates shall not, vote against the recommendation of the Board on specified ordinary course resolutions proposed at a general meeting or annual general meeting of the Company.

The Standstill Agreement shall have effect until the earliest of (i) the Company's AGM in 2028 or (ii) any earlier winding up, liquidation or voluntary corporate reconstruction of the shares and assets of the Company.

 

Enquiries

 

Manulife | CQS Investment Management 

 Craig Cleland

T: +44 (0) 20 7201 5368

Cavendish Capital Markets Limited

Tunga Chigovanyika

 (Corporate Finance)

T: +44 (0) 20 7397 1915

Daniel Balabanoff / Pauline Tribe (Sales)

T: +44 (0) 20 7220 0500

R&H Fund Services (Jersey) Limited

Jane De Barros

T :+44 (0) 1534 825 259

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREAKXFEANSEEA
Date   Source Headline
3rd Jun 202612:22 pmRNSNet Asset Value(s)
2nd Jun 20262:04 pmRNSAppointment of Non-Executive Director
2nd Jun 20261:23 pmRNSNet Asset Value(s)
1st Jun 202612:24 pmRNSNet Asset Value(s)
29th May 20261:30 pmRNSNet Asset Value(s)
28th May 20263:31 pmRNSNet Asset Value(s)
27th May 20264:23 pmRNSNet Asset Value(s)
27th May 202611:57 amRNSMonthly Factsheet - April 2026
26th May 20265:24 pmRNSNet Asset Value(s)
22nd May 20262:06 pmRNSNet Asset Value(s)
21st May 20261:09 pmRNSNet Asset Value(s)
20th May 20263:20 pmRNSNet Asset Value(s)
19th May 20263:08 pmRNSNet Asset Value(s)
18th May 20261:36 pmRNSNet Asset Value(s)
15th May 20264:29 pmRNSPortfolio Management Update
15th May 20262:08 pmRNSNet Asset Value(s)
15th May 202612:42 pmRNSDistribution of Rump proceeds
14th May 20262:50 pmRNSNet Asset Value(s)
13th May 20262:19 pmRNSNet Asset Value(s)
13th May 20261:50 pmRNSHolding(s) in Company
12th May 20263:56 pmRNSHolding(s) in Company
12th May 20263:35 pmRNSDirector/PDMR Shareholding
12th May 20263:28 pmRNSNet Asset Value(s)
11th May 20262:45 pmRNSNet Asset Value(s)
8th May 20263:20 pmRNSNet Asset Value(s)
7th May 20264:28 pmRNSNet Asset Value(s)
7th May 20268:55 amRNSSubscription Rights Rump Placing
6th May 20265:19 pmRNSNet Asset Value(s)
6th May 20267:40 amRNSSubscription Rights for 2027
6th May 20267:28 amRNSSubscription Rights Results 2026
5th May 20264:50 pmRNSNet Asset Value(s)
1st May 20263:14 pmRNSNet Asset Value(s)
30th Apr 20264:08 pmRNSNet Asset Value(s)
29th Apr 20263:00 pmRNSNet Asset Value(s)
28th Apr 20262:52 pmRNSNet Asset Value(s)
28th Apr 202610:10 amRNS-RUpdate research from QuotedData
27th Apr 20262:55 pmRNSNet Asset Value(s)
24th Apr 20262:58 pmRNSNet Asset Value(s)
23rd Apr 20262:55 pmRNSNet Asset Value(s)
23rd Apr 202610:09 amRNSMonthly Factsheet- March 2026
22nd Apr 20261:38 pmRNSNet Asset Value(s)
21st Apr 20262:55 pmRNSNet Asset Value(s)
20th Apr 202612:20 pmRNSNet Asset Value(s)
17th Apr 20263:29 pmRNSNet Asset Value(s)
16th Apr 20262:35 pmRNSNet Asset Value(s)
16th Apr 202610:41 amRNSDirectors intent re subscription rights
15th Apr 20261:29 pmRNSNet Asset Value(s)
14th Apr 20261:11 pmRNSNet Asset Value(s)
14th Apr 20267:52 amRNSNet Asset Value(s)
10th Apr 20261:55 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.